Illegal Ayurvedic Medicines Unit Raided In Vasai By FDA, Medicines Seized

Palghar: A firm in Vasai in Palghar district was raided by the Food and Drug Administration and Ayurvedic medicines manufactured without licence and other items worth Rs 1 crore were seized, an official said on Friday.

The raid was carried out by the Intelligence Branch of FDA, Mumbai on a tip off on Thursday, he said.

“It held a manufacturing licence for Panchkula in Haryana but was carrying out manufacturing activities in its firm in Navghar in Vasai. Further investigation is under progress and suitable legal action would be taken against the said manufacturer after completion of investigation,” the official said.

Related Posts

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Pune:  After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…

Spurious cosmetic packaging factory busted in northwest Delhi

New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Spurious cosmetic packaging factory busted in northwest Delhi

Spurious cosmetic packaging factory busted in northwest Delhi

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

UP plans US FDA-accredited medical device testing lab

UP plans US FDA-accredited medical device testing lab

Patent rejected for MNC’s cancer drug, generics to follow

Patent rejected for MNC’s cancer drug, generics to follow

Zydus brings world’s first Nivolumab biosimilar to India

Zydus brings world’s first Nivolumab biosimilar to India